Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Lipoprotein Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00526058
What this trial is testing

(H.E.L.P.)Apheresis Therapy to Compare the Reduction of LDL (Low Density Lipoprotein) Cholesterol

Who this might be right for
Hypercholesterolemia
B. Braun Medical Inc. 18
Large-scale testing (Phase 3)Study completedNCT02585895
What this trial is testing

Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment

Who this might be right for
Hypercholesterolemia
Amgen 39
Not applicableUnknownNCT04613167
What this trial is testing

Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment

Who this might be right for
Acute Coronary SyndromePremature Coronary Heart DiseaseLipoproteinemia+2 more
University Medical Centre Ljubljana 70
Not applicableLooking for participantsNCT06439654
What this trial is testing

Atlantic Lipid Lowering Treatment Optimization Program

Who this might be right for
Familial HypercholesterolemiaLipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaApolipoprotein B 100, Familial Defective+2 more
Atlantic Health System 250
Large-scale testing (Phase 3)Study completedNCT00136942
What this trial is testing

A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol

Who this might be right for
Hyperlipidemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 370
Large-scale testing (Phase 3)Study completedNCT00082251
What this trial is testing

Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST

Who this might be right for
Hypercholesterolemia
Kos Pharmaceuticals
Not applicableActive Not RecruitingNCT05411887
What this trial is testing

Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab

Who this might be right for
HyperlipidemiasHypertension
Daewoong Pharmaceutical Co. LTD. 2,845
Large-scale testing (Phase 3)Study completedNCT00654485
What this trial is testing

COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects

Who this might be right for
Metabolic Syndrome
AstraZeneca 940
Large-scale testing (Phase 3)Study completedNCT07564726
What this trial is testing

Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol

Who this might be right for
HypertensionHypercholesterolemia
Celltrion Pharm, Inc. 163
Testing effectiveness (Phase 2)Study completedNCT00001752
What this trial is testing

Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women

Who this might be right for
HypercholesterolemiaPostmenopause
National Heart, Lung, and Blood Institute (NHLBI) 30
Large-scale testing (Phase 3)UnknownNCT01109498
What this trial is testing

Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]

Who this might be right for
Familial Lipoprotein Lipase Deficiency
Amsterdam Molecular Therapeutics 14
Not applicableStudy completedNCT04271280
What this trial is testing

Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events

Who this might be right for
DyslipidemiaCardiovascular DiseasesHypercholesterolemia+1 more
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 9,559
Testing effectiveness (Phase 2)Study completedNCT02597127
What this trial is testing

Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Atherosclerotic Cardiovascular DiseaseFamilial HypercholesterolemiaDiabetes
The Medicines Company 501
Large-scale testing (Phase 3)Ended earlyNCT00239681
What this trial is testing

JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

Who this might be right for
Elevated High-sensitivity C-Reactive Protein (hsCRP)
AstraZeneca 17,802
Post-approval studies (Phase 4)Study completedNCT00442325
What this trial is testing

Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

Who this might be right for
Coronary ArteriosclerosisDiabetes Mellitus, Type 2Cerebrovascular Accident+2 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 595
Early research (Phase 1)Study completedNCT02314442
What this trial is testing

An Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Hypercholesterolemia
Alnylam Pharmaceuticals 70
Large-scale testing (Phase 3)Study completedNCT00551447
What this trial is testing

A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)

Who this might be right for
Coronary Disease
Organon and Co 616
Testing effectiveness (Phase 2)Study completedNCT00158899
What this trial is testing

GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol

Who this might be right for
DyslipidaemiasDyslipidaemia
GlaxoSmithKline 424
Post-approval studies (Phase 4)Looking for participantsNCT06903546
What this trial is testing

The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients

Who this might be right for
Diabetes Mellitus Type 2
Universitas Indonesia 64
Not applicableUnknownNCT05513729
What this trial is testing

Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes Mellitus With Complication
First Affiliated Hospital Xi'an Jiaotong University 80
Next Page